IRCT2014122720441N1已完成未知
Effect of omega 3 on inflammatory marker, hs-CRP, and 30-days major adverse cardiac effects (MACE) after percutaneous coronary intervention (PCI) in chronic kidney disease patients (CKD)
Shiraz University of Medical Sciences, International branch0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Informed consent form; NSTE-ACS candidate for elective PCI; treatment with ASA at least 5 days before PCI; CKD patients (GFR ? 60 ml/min) Exclusion criteria: CABG during last 3 months; treatment with glycoprotein IIb/IIIa inhibitors during PCI; treatment with bivalirudine during PCI; sensitivity or tolerance to ASA or Clopidogrel; unsatisfactory PCI; sever active bleeding; sever adverse effects to drugs
排除标准
- 未提供
研究者
相似试验
招募中
不适用
The effect of omega-3 supplementation in COVID-19IRCT20151226025699N3Sabzevar University of Medical Sciences50
已完成
3 期
Omega-3 and inflammation in hemodialysisEnd Stage Renal Disease.Chronic kidney disease, stage 5IRCT201602012417N18Vice Chancellor for Research, Isfahan University of Medical Sciences60
已完成
3 期
The effects of omega-3 supplementation in gestational diabetesGestational diabetes mellitus.O24.4Gestational diabetes mellitusIRCT20170513033941N42Arak University of Medical Sciences60
已完成
不适用
Effect of omega-3 supplementation on inflammatory parameters in patients on chronic ambulatory peritoneal dialysisEnd Stage Renal Disease.End Stage Renal DiseaseIRCT201303052417N11Vice Chancellor for Research, Isfahan University of Medical Sciences40
已完成
不适用
Effect of supplementation in treatment of gestational diabetesGestational diabetes.Diabetes mellitus in pregnancy, unspecifiedO24.9IRCT201406305623N20Arak University of Medical Sciences54